Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a newer version of the site software used to render the ClinicalTrials.gov page. This maintenance update does not modify the study details, eligibility criteria, or results presented on the page.
    Difference
    0.0%
    Check dated 2026-05-15T15:13:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new PubMed-listed publication citation has been added under Publications From PubMed, detailing a substudy related to the SENSCIS trial. This entry connects the trial to additional scholarly work and authors involved.
    Difference
    0.0%
    Check dated 2026-05-08T12:23:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The only visible update is a change in the site’s displayed revision version at the bottom of the page from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:32.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Replaced Padua, Italy, 35128 with Padova, Italy, 35128 to reflect the local official name.
    Difference
    0.0%
    Check dated 2026-04-09T21:47:03.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Systemic sclerosis was added as the disease term and Scleroderma removed where it referred to the same condition.
    Difference
    0.0%
    Check dated 2026-04-02T15:40:58.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.